Description

LORAVIL 10 MG

Indications

LORAVIL 10 MG, containing the active ingredient Loratadine, is primarily indicated for the relief of symptoms associated with allergic rhinitis and chronic urticaria. Allergic rhinitis symptoms include sneezing, runny or itchy nose, and itchy or watery eyes. Chronic urticaria, commonly known as hives, presents with raised, itchy welts on the skin. LORAVIL is effective in alleviating these symptoms, improving the quality of life for patients suffering from allergic conditions.

Mechanism of Action

Loratadine, the active component of LORAVIL, is a second-generation antihistamine that selectively inhibits peripheral H1 receptors. By blocking these receptors, Loratadine prevents the action of histamine, a substance released during allergic reactions that causes symptoms such as itching, swelling, and vasodilation. Unlike first-generation antihistamines, Loratadine is less likely to cross the blood-brain barrier, resulting in minimal sedation and allowing for its use in patients who require alertness throughout the day.

Pharmacological Properties

LORAVIL is rapidly absorbed after oral administration, with peak plasma concentrations typically reached within 1 to 2 hours. The drug has a long half-life of approximately 8 to 14 hours, allowing for once-daily dosing. Loratadine is extensively metabolized in the liver, primarily by cytochrome P450 enzymes, producing an active metabolite, desloratadine, which also possesses antihistaminic properties. The elimination of Loratadine and its metabolites occurs mainly through urine and feces.

Contraindications

LORAVIL is contraindicated in individuals with a known hypersensitivity to Loratadine or any of the excipients in the formulation. Caution should be exercised in patients with severe hepatic impairment, as the metabolism of Loratadine may be significantly affected, leading to increased plasma concentrations and potential toxicity.

Side Effects

The use of LORAVIL is generally well-tolerated. However, some patients may experience side effects, including but not limited to:

• Headache
• Drowsiness
• Fatigue
• Dry mouth
• Nausea
• Gastrointestinal disturbances

Serious side effects are rare but may include allergic reactions such as rash, itching, swelling, or difficulty breathing. Patients should be advised to seek immediate medical attention if they experience any severe or unusual symptoms.

Dosage and Administration

The recommended dosage of LORAVIL for adults and children over the age of 12 is 10 mg once daily. For children aged 6 to 12 years, the recommended dose is 5 mg once daily. LORAVIL can be taken with or without food. It is important not to exceed the recommended dosage to minimize the risk of adverse effects.

Interactions

LORAVIL may interact with other medications, particularly those that inhibit or induce cytochrome P450 enzymes. Drugs such as ketoconazole, erythromycin, and cimetidine may increase plasma levels of Loratadine, potentially leading to enhanced side effects. Conversely, medications that induce liver enzymes, such as rifampicin, may decrease the effectiveness of LORAVIL. Patients should inform their healthcare provider of all medications they are currently taking to avoid potential interactions.

Precautions

Patients with pre-existing medical conditions, such as liver disease or renal impairment, should use LORAVIL with caution. Additionally, while LORAVIL is less sedating than first-generation antihistamines, it is advisable for patients to avoid activities requiring mental alertness, such as driving or operating heavy machinery, until they know how the medication affects them. Pregnant or breastfeeding women should consult their healthcare provider before using LORAVIL to weigh the potential benefits against any risks.

Clinical Studies

Clinical studies have demonstrated the efficacy of Loratadine in managing allergic rhinitis and chronic urticaria. In a randomized, double-blind, placebo-controlled trial, patients receiving LORAVIL reported significant improvements in nasal and ocular symptoms compared to those receiving a placebo. Another study indicated that Loratadine effectively reduced the severity and frequency of hives in patients with chronic urticaria. These findings support the use of LORAVIL as a safe and effective option for the management of allergic symptoms.

Conclusion

LORAVIL 10 MG is a well-established antihistamine that provides effective relief from the symptoms of allergic rhinitis and chronic urticaria. Its favorable pharmacokinetic profile, coupled with a low incidence of sedation, makes it a preferred choice for patients requiring long-term management of allergic conditions. As with any medication, it is essential for patients to follow dosing recommendations and consult healthcare professionals regarding any potential interactions or contraindications.